Literature DB >> 12091490

Native LDL potentiate TNF alpha and IL-8 production by human mononuclear cells.

Mihai G Netea1, Bart Jan Kullberg, Pierre N M Demacker, Liesbeth E H Jacobs, Trees J G Verver-Jansen, Anneke Hijmans, Lambertus H J van Tits, Joost G J Hoenderop, Peter H G M Willems, Jos W M Van der Meer, Anton F H Stalenhoef.   

Abstract

Native LDL (nLDL) increases expression of adhesion molecules on endothelial cells through induction of Ca(2+) mobilization. Ca(2+) mobilization is also involved in the induction of proinflammatory cytokines, important mediators involved in atherogenesis. The aim of the study was to evaluate the capacity of nLDL to affect spontaneous and lipopolysaccharide (LPS)-stimulated cytokine production. Preincubation of human peripheral blood mononuclear cells (PBMC) with nLDL for 24 h did not influence spontaneous production of tumor necrosis factor alpha (TNF alpha) or interleukin-8 (IL-8), but significantly potentiated LPS-induced production of these cytokines. nLDL preincubation of PBMC did not increase the expression of the LPS receptors Toll-like receptor-4, CD14, or CD11c/CD18. Potentiation of cytokine production by nLDL was mediated through induction of Ca(2+) mobilization, because: a) nLDL induced a sustained pattern of repetitive Ca(2+) transients in human PBMC; b) the Ca(2+) chelator fura 2-acetoxymethyl ester, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, an intracellular Ca(2+) chelator, inhibited the potentiating effect of nLDL on LPS-induced cytokine synthesis; c) induction of Ca(2+) mobilization by thapsigargin potentiated LPS-induced cytokine production. nLDL are able to potentiate LPS-induced production of cytokines by human PBMC, and this effect is probably mediated through induction of Ca(2+) mobilization. This may represent an important pathogenetic mechanism in atherogenesis induced by hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091490     DOI: 10.1194/jlr.m100254-jlr200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels.

Authors:  John S Millar; Bonnie Ky; Megan L Wolfe; Leticia Pruscino; Amanda Baer; Daniel J Rader
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

2.  Effects of rosiglitazone on native low-density-lipoprotein-induced respiratory burst in circulating monocytes and on the leukocyte-endothelial interaction in cholesterol-fed rats.

Authors:  Long Sheng Lu; Li Man Hung; Chang Hui Liao; Chau Chung Wu; Ming Jai Su
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-04-21       Impact factor: 3.000

3.  Lipoproteins attenuate TLR2 and TLR4 activation by bacteria and bacterial ligands with differences in affinity and kinetics.

Authors:  Jeroen van Bergenhenegouwen; Aletta D Kraneveld; Lieke Rutten; Johan Garssen; Arjan P Vos; Anita Hartog
Journal:  BMC Immunol       Date:  2016-10-28       Impact factor: 3.615

4.  Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages.

Authors:  Feroz Ahmad; David S Leake
Journal:  J Lipid Res       Date:  2018-11-05       Impact factor: 5.922

Review 5.  Electronegative LDL: a circulating modified LDL with a role in inflammation.

Authors:  Montserrat Estruch; José Luis Sánchez-Quesada; Jordi Ordóñez Llanos; Sònia Benítez
Journal:  Mediators Inflamm       Date:  2013-08-22       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.